Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Press releases

August 24, 2016 | REGULATORY

Immunovia Half-year report 2016

Read press release
August 17, 2016 | REGULATORY

Immunovia invitation to a teleconference on 24 August 2016

Read press release
August 16, 2016 | REGULATORY

Immunovia announces intention to apply for listing on Nasdaq Stockholm’s Main Market

Read press release
July 15, 2016 | REGULATORY

Prof. Diane Simeone from University of Michigan Medical Center becomes latest appointment to Immunovia Scientific Advisory Board

Read press release
July 5, 2016 | REGULATORY

World leading cancer diagnostics expert, Professor Aldo Scarpa appointed to Immunovia’s Scientific Advisory Board

Read press release
June 23, 2016 | REGULATORY

Leading US gastrointestinal cancer expert, Professor Margaret Tempero appointed to Immunovia’s Scientific Advisory Board

Read press release
May 31, 2016 | REGULATORY

Stämmokommuniké

Read press release
May 30, 2016 | REGULATORY

Double pancreatic cancer survival by 2020

Read press release
May 30, 2016 | REGULATORY

96 % of early stage pancreatic cancer patients detected in a clinical validation study with a North American sample cohort

Read press release
May 18, 2016

Inbjudan till Immunovia Informationsmöte i Stockholm den 1 juni kl 17.30 med VD MatsGrahn och Styrelseordförande Carl Borrebaeck

Read press release
May 9, 2016

IMMUNOVIA JOINS MORE THAN 40 GLOBAL PANCREATIC CANCER ORGANIZATIONS AT INAGURAL MEETING

Read press release
April 26, 2016 | REGULATORY

Immunovia kallar till årsstämma 2016

Read press release
1 … 23 24 25 26 27
Home Press releases Page 25